Gabriela Gruia
CIK 1860326 · Interim Chief Medical Officer · last filed 2026-06-17
Gabriela Gruia is an Interim Chief Medical Officer who has filed 14 SEC Form 4 insider transactions across 3 companies since 2021. The most recent filing, for APRE, was dated Jun 17, 2026. Current disclosed insider exposure totals $2.6K across reported positions.
"Disclosed insider exposure" sums this person's most-recently-reported share counts across each company they're an insider in, multiplied by the current underlying price. It is not net worth — it misses retail holdings, private investments, real estate, index funds, and any company where the person isn't an SEC-reporting insider. For informational purposes only.
$2.6K
3
14
$0
Holdings By Company
Recent Filings
14 filings| Filed | Symbol | Action | Net Shares | Net $ | Link |
|---|---|---|---|---|---|
| 2026-06-17 | APRE | Grant (A) | +3,135 | $0 | EDGAR |
| 2026-05-22 | TCRX | Grant (A) | — | $0 | EDGAR |
| 2025-07-02 | TCRX | Grant (A) | — | $0 | EDGAR |
| 2025-06-09 | APRE | Grant (A) | +1,045 | $0 | EDGAR |
| 2024-09-30 | Molecular Templates, Inc. (MTEM) Delisted | Grant (A) | — | $0 | EDGAR |
| 2024-06-14 | TCRX | Grant (A) | — | $0 | EDGAR |
| 2023-10-31 | Molecular Templates, Inc. (MTEM) Delisted | Grant (A) | — | $0 | EDGAR |
| 2023-08-31 | Molecular Templates, Inc. (MTEM) Delisted | Grant (A) | — | $0 | EDGAR |
| 2023-06-15 | TCRX | Grant (A) | — | $0 | EDGAR |
| 2023-05-08 | APRE | Grant (A) | — | $0 | EDGAR |
Notice (144 / 144/A): Form 144 is a notice of intent to sell restricted/control stock under Rule 144, filed before the sale; 144/A is an amendment. Many notices are pre-scheduled under Rule 10b5-1 plans. A Form 4 with code S typically follows within a few days when the planned sale executes; missing follow-up Form 4s suggest the notice was cancelled or modified.